Medicines Company (MDCO-OLD)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| History |
Portfolio Manager |
Activity ▲ |
Share change |
% change to portfolio |
| Q1 2020 |
| ≡ |
First Eagle Investment Management |
Sell 100.00% |
409,112 |
0.10 |
| ≡ |
David Einhorn - Greenlight Capital |
Sell 100.00% |
229,900 |
1.45 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
2,176,487 |
2.69 |
| Q4 2019 |
| ≡ |
David Einhorn - Greenlight Capital |
Reduce 68.58% |
501,700 |
3.16 |
| ≡ |
First Eagle Investment Management |
Reduce 46.45% |
354,900 |
0.09 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 43.96% |
1,707,552 |
2.11 |
| Q3 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 0.44% |
16,956 |
0.01 |
| Q2 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 1.38% |
52,731 |
0.03 |
| ≡ |
David Einhorn - Greenlight Capital |
Reduce 22.89% |
217,200 |
0.58 |
| Q1 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 8.52% |
299,375 |
0.11 |
| Q4 2018 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 157.54% |
2,150,140 |
0.61 |
| Q3 2018 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 13.24% |
159,556 |
0.06 |
| ≡ |
David Einhorn - Greenlight Capital |
Reduce 5.12% |
51,200 |
0.06 |
| Q2 2018 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 33.00% |
299,030 |
0.13 |
| Q1 2018 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
906,251 |
0.39 |
| Q4 2017 |
| ≡ |
David Einhorn - Greenlight Capital |
Buy |
1,000,000 |
0.50 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.